$OGNPotential end of a 5 wave pattern here. Looking for some type of retracement. Maybe a start of an "ABC" correction pattern. Taking profit on the "A".
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.245 EUR
834.61 M EUR
6.19 B EUR
257.08 M
About Organon & Co.
Sector
Industry
CEO
Kevin Ali
Website
Headquarters
Jersey City
Founded
2020
FIGI
BBG01K3WCTQ5
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
$OGN*For share traders only. Not meant for options.
Green: Entry Point
Blue: Start of Week
Red: End of Week
Thumbs Up: Trade Available for Week
$ Amount (Numbers Above): Price Targets
*I don’t believe in sharing strategies or outlooks due to the idea that it could cause someone confusion within. It’
OGN Harmonic: Monthly Deep-Crab Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. OGN has a moderate quantitative fundamental score (Greater than 5) with go
$OGN LongEverything you say
Can be heard through the white noise
And we can never stay up in arms
I think the end of Roe v. Wade is exactly what this ice cube needs.
$OGN - nice move OGN has had a nice move back to ATH. Now I would expect some consolidation and then higher as long as there is not a bad ER. New stock so be careful of traps. Analysts do not favor it really but that does not mean much.
OGN OpportunityI like everything about OGN, but the most important aspect of this company is it's incredibly low P/E compared to growth. With this IPO'ing last year, I don't think investors have had enough time to grasp the potential growth of this company. Or perhaps not enough investors are following along. Eith
OGN 20% potential I believe OGN has a great future ahead of it. With a P/E of 4-5, I think this stock has plenty of upward potential in the coming years. As for now, OGN is incredibly undervalued and based on fibs I see a move back up to its resistance at 36 in the near term. Calls are highly favored for this stock.
proposed completed WXY long setup for $OGNelliot wave theory = game genie
i almost always need both geometry and fibs to support a proposed count along with divergence confirmation but this time no obvious support from various fib pulls. however even if the count is wrong, very likely to bounce its just a question of how much. 3-4-5 to 1
OGN Major Upside PotentialHello traders / investors, im looking at OGN as a potential swing opportunity to the the upside, its IPO date was June 7th 2021 with an all time high of 38.24 and then sold off followed by a period of consolidation.
The Weekly chart is showing Bull interest is kicking in.
I do not know much abou
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MRK5164077
Organon Finance 1 LLC 5.125% 30-APR-2031Yield to maturity
9.87%
Maturity date
Apr 30, 2031
MRK5808585
Organon & Co. 7.875% 15-MAY-2034Yield to maturity
8.02%
Maturity date
May 15, 2034
MRK5164075
Organon Finance 1 LLC 4.125% 30-APR-2028Yield to maturity
6.76%
Maturity date
Apr 30, 2028
MRK5808583
Organon & Co. 6.75% 15-MAY-2034Yield to maturity
6.60%
Maturity date
May 15, 2034
XS233225070
ORGANON/ORG.F. 21/28 REGSYield to maturity
5.45%
Maturity date
Apr 30, 2028
See all 1OGN bonds
Related stocks
Frequently Asked Questions
The current price of 1OGN is 14.400 EUR — it hasn't changed in the past 24 hours. Watch ORGANON & CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange ORGANON & CO stocks are traded under the ticker 1OGN.
1OGN stock hasn't changed in a week, the last month showed zero change in price, over the last year ORGANON & CO has showed a −14.18% decrease.
We've gathered analysts' opinions on ORGANON & CO future price: according to them, 1OGN price has a max estimate of 26.48 EUR and a min estimate of 13.70 EUR. Watch 1OGN chart and read a more detailed ORGANON & CO stock forecast: see what analysts think of ORGANON & CO and suggest that you do with its stocks.
1OGN reached its all-time high on Jul 31, 2024 with the price of 21.710 EUR, and its all-time low was 10.000 EUR and was reached on Dec 8, 2023. View more price dynamics on 1OGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1OGN stock is 0.00% volatile and has beta coefficient of 0.21. Track ORGANON & CO stock price on the chart and check out the list of the most volatile stocks — is ORGANON & CO there?
Today ORGANON & CO has the market capitalization of 2.57 B, it has decreased by −12.35% over the last week.
Yes, you can track ORGANON & CO financials in yearly and quarterly reports right on TradingView.
ORGANON & CO is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
1OGN earnings for the last quarter are 0.87 EUR per share, whereas the estimation was 0.84 EUR resulting in a 3.79% surprise. The estimated earnings for the next quarter are 0.85 EUR per share. See more details about ORGANON & CO earnings.
ORGANON & CO revenue for the last quarter amounts to 1.54 B EUR, despite the estimated figure of 1.54 B EUR. In the next quarter, revenue is expected to reach 1.41 B EUR.
1OGN net income for the last quarter is 105.29 M EUR, while the quarter before that showed 322.43 M EUR of net income which accounts for −67.34% change. Track more ORGANON & CO financial stats to get the full picture.
Yes, 1OGN dividends are paid quarterly. The last dividend per share was 0.27 EUR. As of today, Dividend Yield (TTM)% is 9.91%. Tracking ORGANON & CO dividends might help you take more informed decisions.
ORGANON & CO dividend yield was 7.51% in 2024, and payout ratio reached 33.59%. The year before the numbers were 7.77% and 28.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 15, 2025, the company has 10 K employees. See our rating of the largest employees — is ORGANON & CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORGANON & CO EBITDA is 1.71 B EUR, and current EBITDA margin is 27.72%. See more stats in ORGANON & CO financial statements.
Like other stocks, 1OGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORGANON & CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORGANON & CO technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORGANON & CO stock shows the neutral signal. See more of ORGANON & CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.